Annual ROE
-69.12%
-22.56%-48.45%
December 31, 2023
Summary
- As of February 7, 2025, RXRX annual return on equity is -69.12%, with the most recent change of -22.56% (-48.45%) on December 31, 2023.
- During the last 3 years, RXRX annual ROE has fallen by -111.30% (-263.87%).
- RXRX annual ROE is now -238.80% below its all-time high of 49.80%, reached on December 31, 2019.
Performance
RXRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-78.32%
+1.25%+1.57%
September 30, 2024
Summary
- As of February 7, 2025, RXRX quarterly return on equity is -78.32%, with the most recent change of +1.25% (+1.57%) on September 30, 2024.
- Over the past year, RXRX quarterly ROE has increased by +2.10% (+2.61%).
- RXRX quarterly ROE is now -273.24% below its all-time high of 45.21%, reached on March 31, 2021.
Performance
RXRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
RXRX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.5% | +2.6% |
| 3 y3 years | -263.9% | -53.6% |
| 5 y5 years | -238.8% | -53.6% |
RXRX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.5% | +37.6% | -81.9% | +2.6% |
| 5 y | 5-year | -238.8% | +37.6% | -273.2% | +57.1% |
| alltime | all time | -238.8% | +37.6% | -273.2% | +57.1% |
Recursion Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -78.32%(-1.6%) |
| Jun 2024 | - | -79.57%(-1.1%) |
| Mar 2024 | - | -80.42%(+12.1%) |
| Dec 2023 | -69.12%(+48.5%) | -71.74%(+8.4%) |
| Sep 2023 | - | -66.16%(+12.5%) |
| Jun 2023 | - | -58.81%(+5.7%) |
| Mar 2023 | - | -55.66%(+9.1%) |
| Dec 2022 | -46.56% | -51.00%(+1.7%) |
| Sep 2022 | - | -50.16%(+16.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -43.06%(-16.8%) |
| Mar 2022 | - | -51.76%(-25.3%) |
| Dec 2021 | -110.79%(-362.7%) | -69.30%(-5.6%) |
| Sep 2021 | - | -73.43%(-59.8%) |
| Jun 2021 | - | -182.54%(-503.8%) |
| Mar 2021 | - | 45.21%(+7.2%) |
| Dec 2020 | 42.18%(-15.3%) | - |
| Dec 2020 | - | 42.18% |
| Dec 2019 | 49.80% | - |
FAQ
- What is Recursion Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual ROE year-on-year change?
- What is Recursion Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly ROE year-on-year change?
What is Recursion Pharmaceuticals annual return on equity?
The current annual ROE of RXRX is -69.12%
What is the all time high annual ROE for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual return on equity is 49.80%
What is Recursion Pharmaceuticals annual ROE year-on-year change?
Over the past year, RXRX annual return on equity has changed by -22.56% (-48.45%)
What is Recursion Pharmaceuticals quarterly return on equity?
The current quarterly ROE of RXRX is -78.32%
What is the all time high quarterly ROE for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly return on equity is 45.21%
What is Recursion Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, RXRX quarterly return on equity has changed by +2.10% (+2.61%)